Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials
2011

Teriparatide Therapy for Bone Healing

Sample size: 102 publication 10 minutes Evidence: moderate

Author Information

Author(s): Robinder S. Dhillon, Edward M. Schwarz

Primary Institution: University of Rochester

Hypothesis

Can teriparatide enhance the healing of massive allografts and improve bone repair in critically sized defects?

Conclusion

Teriparatide shows promise as an effective adjuvant therapy for enhancing bone healing and integration of allografts.

Supporting Evidence

  • Teriparatide enhances skeletal repair through various mechanisms.
  • Intermittent PTH treatment has been shown to improve bone formation.
  • Clinical case reports suggest teriparatide can heal non-unions effectively.

Takeaway

Teriparatide is a medicine that helps bones heal better, especially when they are really hurt or broken.

Methodology

The study reviews existing literature and animal studies on the effects of teriparatide on bone healing.

Potential Biases

Potential bias due to reliance on case reports and limited clinical trials.

Limitations

The clinical evidence for widespread teriparatide use remains limited and mostly anecdotal.

Participant Demographics

Postmenopausal women and patients with various bone healing issues.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/ma4061117

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication